Previously, we generated a novel monoclonal antibody (mAb), MY.1E12, which preferentially recognizes sialylated MUC1 mucin (Yamamoto et al, 1996) . In this study, we used mAb MY.1E12 to detect sialylated MUC1 mucin in formalin-fixed, paraffin-embedded surgical specimens from RCC of various histological grades and at different stages of progression. A correlation between the level of expression of sialylated MUC1 mucin and the survival of patients was demonstrated.
MATERIALS AND METHODS

Specimens
Fifty-one specimens of RCC were obtained from patients who had undergone radical nephrectomy at Juntendo University. All specimens were classified by pathologists according to the TNM system (International Union Against Cancer, 1987) UICC staging (International Union Against Cancer, 1992) and pathological grading based on the nuclear atypia (Japanese Urological Association, 1992) . In half of the cases, the renal cortex, medulla and carcinoma were sampled before formalin fixation and were kept frozen at -80°C until use. Specimens from metastatic sites were also obtained from autopsy cases.
A cell line and a mAb
Capan-1 pancreatic adenocarcinoma cell lines were obtained from Dr Marsha L Frazier of the Department of Epidemiology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. The cells were maintained in a 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F12 medium that contained 10% fetal calf serum in a humidified atmosphere that contained 5% carbon dioxide at 37°C. mAb MY.1E12 (IgG2a), specific for MUC1 mucin with sialylated O-linked oligosaccharides, was prepared as described previously (Yamamoto et al, 1996) . The epitope structure recognized by this mAb was previously described (Yamamoto et al, 1996) .
Immunohistochemical staining
Surgical specimens fixed in formalin and embedded in paraffin were cut at 4 µm. The sections were deparaffinized and treated with 0.3% hydrogen peroxide in methanol for 30 min to block endogenous peroxidase activity. The sections were rehydrated in phosphate-buffered saline (PBS) and incubated with 2% bovine serum albumin (BSA) in PBS for 40 min at room temperature (r.t.). mAb MY.1E12 (culture supernatant of the hybridoma cells) was diluted 1:1 in PBS containing 2% BSA. The sections were incubated with the diluted mAb MY.1E12 for 1 h at 37°C. After washing with PBS, the sections were incubated with biotinylated goat anti-mouse immunoglobulin (DAKO JAPAN Co., Ltd, Kyoto, Japan) for 40 min at r.t. The specimens were washed with PBS and incubated with a solution of horseradish peroxidaseconjugated streptavidin (DAKO JAPAN Co., Ltd) for 40 min at r.t. After repeated washing, they were treated with DAB reagent, which consisted of a 0.05% solution of 3,3′-diaminobenzidine (Sigma, St Louis, MO, USA) dissolved in 10 ml of PBS and 3 µl of 30% hydrogen peroxide. The specimens were counterstained with haematoxylin.
In some experiments, deparaffinized and hydrogen peroxidasetreated sections were incubated with sialidase (Vibrio cholerae, 50 mU ml -1 in PBS; Calbiochem, La Jolla, CA, USA) at 37°C for 3 h (Matsushita et al, 1990) . After several washings with PBS, the sections were treated with mAb MY.1E12 and processed as described above.
Western blot analysis
The frozen surgical specimens were thawed and homogenized with 0.5% Nonidet P-40 in a desalting buffer that consisted of 250 mM sucrose, 10 mM Tris-HCl, 50 µM calcium chloride and 10 mM phenylmethylsulphonyl fluoride, pH 7.2. The Capan-1 cells were also lysed in the same buffer. The supernatants of the lysates were mixed with one half volume of 187.5 mM Tris-HCl that contained 5% sodium dodecyl sulphate, 3% 2-mercaptoethanol, 30% glycerol and 1.5 mM EDTA. The mixtures containing 200 µg of protein were heated for 5 min at 100°C and then electrophoretically separated on 4% polyacrylamide gels in the presence of 0.1% sodium dodecyl sulphate (SDS-PAGE). They were transblotted onto polyvinylidene difluoride membranes (Immobilon; Millipore, Boston, MA, USA). The membranes were incubated in 2% BSA in PBS at 4°C overnight and then mixed with mAb MY.1E12 (culture supernatant of hybridoma cells) diluted in an equal volume of 2% BSA for 2 h at r.t. After washing with PBS that contained 0.1% Tween-20, they were incubated with rabbit anti-mouse IgG labelled with alkaline phosphatase (Zymed Laboratories Inc., San Francisco, CA, USA) for 1 h at r.t. The membranes were washed with PBS that contained 0.1% Tween-20 and then treated with ECL (Amersham, Buckinghamshire, UK) to visualize the antibodies that were bound.
Statistical analysis
Statistical analysis was performed using Student's t-test. The survival of patients and recurrence of disease were recorded every month. Patient survival was analysed by the method of Kaplan and Meier (1977) . Disease-free survival of patients undergoing curative surgery was analysed by the same method. Differences in the survival of patients in subgroups that were classified according to reactivity with mAb MY.1E12 were analysed by the log-rank test.
RESULTS
Immunohistochemical localization of sialylated MUC1 mucin in normal kidney
The luminal surfaces of the distal convoluted tubules, collecting ducts and Henle's loops were strongly stained with mAb MY.1E12, but the proximal convoluted tubules and Bowman's capsules were not (Figure 1 ). This reactivity with mAb MY.1E12 was completely abolished by sialidase treatment of the specimens (data not shown).
Immunohistochemical localization of sialylated MUC1 mucin in RCC
The staining pattern of mAb MY.1E12 in RCC demonstrated that the distribution of sialylated MUC1 mucin in the tumour was heterogeneous. A cell was judged to be positively stained when either the cytoplasm or the whole cell membrane was stained. Conversely, when only the apical side of the membrane was stained it was judged to be negative. To quantitate the degree of reactivity with mAb MY.1E12, the percentage of positively stained cells in all tumour cells (positive rate) was determined for each specimen. The levels of expression of sialylated MUC1 mucin in 51 surgical specimens of RCC are summarized in Table 1 . Primary tumours that had already metastasized to distant organs (M1) were stained more strongly than tumours that had not metastasized (M0) (P < 0.001). Moreover, primary tumours that had metastasized to the regional lymph nodes (pN1-3) were also stained more strongly than the tumours that had not (pN0) (P < 0.05). No difference in reactivity was found between tumours that were limited to the kidney (pT1-2) and those that had invaded beyond the kidney (pT3-4). Reactivity to the antibody was not affected by the size of the tumour or the age and sex of the patients. RCC at UICC stage 3 or 4 (advanced stage of cancer progression) showed higher expression of sialylated MUC1 mucin than RCC at stage 1 or 2 (P < 0.001).
This pathologic grading used in the study presented here is based on the nuclear atypia of the tumour. Grade 1 tumours, which had nuclei resembling the nuclei of proximal convoluted tubule cells, showed weak reactivity with the mAb (Figure 2 ). Grade 2 tumours, which had larger or irregular nuclei with nucleoli, showed moderate reactivity (Figure 3 ). Grade 3 tumours, which had bizarre or giant nuclei, reacted strongly with the mAb (Figure  4 ). Sialidase treatment completely abolished the reactivity of the RCC specimens with mAb MY.1E12.
Tissues of metastasis of distant organs were obtained from six autopsy cases. The immunohistochemical reactivity to MY.1E12 was high for all the tissues (positive rate: 69.0 ± 40.4). 
Figure 5
Relationship between the prognosis and expression of sialylated MUC1 mucins in the RCC specimens by Kaplan-Meier's survival curve. The patients with RCC were divided into two groups according to the percentage of stained cells in the cancer specimens: Group A, which had greater or equal to 5% of the cells stained, and Group B, which had less than 5% of the cells stained (P = 0.009 according to the log-rank test)
Relationship between the prognosis or disease-free survival of patients with RCC and expression of sialylated MUC1 mucin in the specimens
The patients with RCC were divided into two groups according to the percentage of stained cells in the cancer specimens: Group A, which had greater or equal to 5% of the cells stained, and Group B, which had less than 5% of the cells stained. The survival curves of the patients in these two groups were drawn by the method of Kaplan-Meier ( Figure 5 ). The prognosis of the patients in Group A was significantly poorer than that of the patients in Group B (P = 0.009). The 5-year survival rate was 47.2% in Group A and 85.7% in Group B. The disease-free survival of patients who had undergone curative surgery is shown in Figure 6 . It should be noted that none of the patients subjected to this comparison had detectable metastasis at the time of surgery. The patients in Group A developed metastasis more frequently than the patients in Group B (P = 0.034). The survival curves were also compared within restricted categories. In Figure 7A , a total of 27 patients who did not have detectable metastasis at the time of surgery (N0M0) were compared according to mAb MY.1E12 binding. The difference between the MUC1 mucin-positive group and MUC1 mucin-negative group was statistically significant (P = 0.043). When a total of 32 patients categorized as T1 and T2 (confined tumours) were compared, significant difference in the survival between patients with stained tumours and unstained tumours was also observed (P = 0.010) ( Figure 7B ). Patients with MUC1 mucin-positive tumours showed significantly poorer survival than those with MUC1 mucin-negative tumours (P = 0.014), when patients with tumour cells having grade 1 and grade 2 nuclear atypia were examined ( Figure 7C ).
Western blot analysis of sialylated MUC1 mucin in normal kidney, RCC and Capan-1 cell lines
Normal kidney tissues were obtained from an area approximately 3 cm from the primary RCC. The cortex and medulla of the normal tissue were separated macroscopically. The cortex contained distal and proximal convoluted tubules and Bowman's capsules. The medulla contained collecting ducts and Henle's loops. Sialylated MUC1 mucin in the lysates of the normal cortex and medulla, RCC and Capan-1 cell lines was detected with mAb MY.1E12 after SDS-PAGE (Figure 8 ). When normal tissue and RCC from the same patients were compared, normal tissue contained components with slower mobility than RCC. RCC and Capan-1 cells from one patient (lane 8) apparently contained two distinct bands corresponding to two alleles of MUC1 gene. Sialylated MUC1 mucin of RCC from five patients (corresponding to lanes 4, 6, 7, 9 and 10) had similar electrophoretic migration corresponding to an apparent M r 400 000.
DISCUSSION
The expression of MUC1 mucin by RCC at various stages of progression was demonstrated. Primary lesions with distant organ metastasis (M1) or lymph node metastasis (pN1-3) were stained more strongly by the mAb specific for sialylated MUC1 mucin than lesions without metastasis (P < 0.001 and 0.05 respectively). Among patients who had undergone surgery with curative intent for localized cancer (pT1-3, pN0, M0), the patients with a high level of MUC1 mucin expression had a poorer disease-free survival rate than the patients with a low level of MUC1 mucin expression (P < 0.05). These results indicate that RCC cells with high MUC1 mucin expression have a strong potential for metastasis, and that micrometastases may already exist at the time of surgery if the expression of MUC1 mucin was high at the primary lesion. There were no significant differences in MUC1 mucin expression between cancer that was confined within the kidney (pT1-2) and cancer that was invasive through the renal capsule into the perinephric fat (pT3-4). The size of the tumour did not affect the expression of MUC1 mucin. These results are consistent with our previous findings on colon carcinoma cells indicating that primary tumours at advanced stages expressed increased levels of MUC1 mucin (Nakamori et al, 1994) . RCC cells were histologically divided into three grades based on the degree of nuclear atypia (Japanese Urological Association, 1992). RCCs in grade 1 (well-differentiated) had nuclei which resembled that of proximal convoluted tubules. These RCCs expressed MUC1 mucin weakly and the cells sometimes preserved the polar nature of its localization. Most RCCs in grade 2 or 3 (moderately or poorly differentiated) expressed MUC1 mucin strongly at the surface of the cell membranes and in the cytoplasm. Due to such strong association with histological grades and stages of the disease, the increased sialylated MUC1 mucin revealed by mAb MY.1E12 is not considered to be an independent prognostic marker. However, this phenotype should serve as a unique biological feature associated with advanced RCC.
MUC1 mucin is a long and rigid glycoprotein that extrudes out of the cell membrane and is negatively charged due to the addition of sialic acids. In normal glandular cells, MUC1 mucin is expressed only on the apical (luminal) side of the cells. The charge repulsion caused by the sialic acids and the rigid structures of the mucins apparently maintain the lumen of the gland and prevent attachment of foreign molecules or cells. In most cancer cells, this polarization is lost and overexpression of MUC1 mucin on the whole cell membrane is believed to destabilize the cell-cell adhesion and to permit cancer cells to migrate and metastasize . This tendency to lose homotypic cell adhesion was experimentally observed under the influence of a potent adhesion molecule, E-cadherin, as reported by Hilkens and co-workers. They used double transfectant cells that expressed both MUC1 mucin and E-cadherin to show that MUC1 mucin could prevent intercellular adhesion mediated by E-cadherin Wesseling et al, 1996) . In these studies, however, sialic acid at the termini of carbohydrate chains did not seem to play roles. Although the present study utilized with a mAb specific for sialylated MUC1 mucin, our preliminary experiments with mAb specific for core polypeptide portions of MUC1 mucin also showed similar differences in their bindings to low-and highgrade RCC. A decrease in E-cadherin function was proposed to favour the detachment of cells in most carcinomas, resulting in a more aggressive tumour (Takeichi, 1991; Birchmeier and Behrens, 1994) . However, the frequency of expression of E-cadherin in RCC seems to be very low regardless of the grade. Even low-grade RCCs do not express E-cadherin. Furthermore, the normal proximal convoluted tubules, where RCC is considered to originate (Oosterwijk et al, 1986; Mackay et al, 1987) , do not express Ecadherin (Terpe et al, 1993; Katagiri et al, 1995) . Therefore, MUC1 mucin may be antagonizing other adhesion molecules in RCC.
As stated above, RCC originates from the proximal convoluted tubules. Our immunohistochemical study of normal kidney tissues demonstrated that MUC1 mucin is absent in the proximal convoluted tubules, but present on cell surfaces of the distal convoluted tubules, collecting ducts and Henle's loops. MUC1 mucin is detected mainly on the apical side of these cells. In the process of malignant transformation from the proximal convoluted tubules, RCC cells acquire the ability to express MUC1 mucin. Figure 8 Binding of mAb MY.1E12 to electrophoretically separated lysates of normal kidney tissues, RCC and Capan-1 cells. Lane 1 is the lysate of Capan-1 cells. Lane 2 is the lysate of the normal medulla of the kidney, which contains Henle's loops and collecting ducts. Lane 3 is the lysate of the normal cortex of the kidney, which contains Bowman's capsules, proximal convoluted tubules and distal convoluted tubules. Lane 4 is the lysate of grade 2, pT3N0M1 RCC. Lane 5 is the lysate of the normal cortex of the kidney. Lane 6 is the lysate of grade 2, pT3N0M0 RCC. Lane 7 is the lysate of grade 1, pT2N0M0 RCC. Lane 8 is the lysate of grade 3, pT3N1M1 RCC. Lane 9 is the lysate of grade 2, pT2N0M1 RCC. Lane 10 is the lysate of grade 3, pT2N0M1 RCC. These cell lysates were subjected to SDS-PAGE using 4% gels, followed by blotting onto polyvinylidene difluoride membranes. The membranes were processed for detection of sialylated MUC1 mucin, as described in Materials and Methods. Samples obtained from the same patient are bracketed Electrophoretic analysis revealed slight differences in the apparent M r of MUC1 mucin expressed in malignant cells and normal cells (collecting ducts, distal convoluted tubules and Henle's loops). Such altered glycosylation and sialylation in RCC might influence the reactivity of MUC1 mucin with MY.1E12. Thus, there is a possibility that this antibody does not react with a portion of a mixture of diversely glycosylated MUC1 mucin, resulting in unique banding patterns revealed by Western blot analysis. It remains to be elucidated whether these differential migrations were due to changes in the number of O-linked carbohydrate chains or extension of carbohydrate chains.
van der reported that melanoma cells transfected with MUC1 genes are resistant to killing by cytotoxic T-cells and lymphokine-activated killer cells. We reported previously that colon carcinoma cells with high MUC1 mucin production are less sensitive to cytolysis by lymphokine-activated killer cells . These data suggest that a greater amount of MUC1 mucin on RCC cells may conceal putative recognition sites for these killer lymphocytes. This would increase the chance of survival and colonization of RCC cells by allowing them to evade immune surveillance. It is also possible that the alteration in MUC1 mucin expression is simply associated with the status of differentiation of RCC and may not influence the cells' malignant behavior.
The mechanistic basis for the increase of mAb MY.1E12-reactive MUC1 mucin in high-grade RCC is not known. Host microenvironmental factors may affect the production of MUC1 mucin. We reported that a soluble factor, produced by connective tissue of the colon, increased the expression of MUC1 mucin by colon carcinoma cells in vitro Dohi et al, 1993; Shirotani et al, 1994) . A higher level of expression of MUC1 mucin was observed in RCC cells adjacent to the connective tissue of the kidney ( Figure 3B ), suggesting that a similar protein that increases expression of MUC1 mucin may be produced by the interstitium of the kidney.
